IP Library › Granted Patent US 8,518,939
Granted Patent B2
US 8,518,939 · App. 13/467,302 · Granted Aug 27, 2013

6-pyrimidinyl-pyrimid-4-one derivative

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,518,939
App. No.
13/467,302
Granted
Aug 27, 2013
Kind
B2
Abstract

A compound represented by the formula (I) or a pharmaceutically acceptable salt thereof: which is used for preventive and/or therapeutic treatment of a disease caused by abnormal activity of tau protein kinase 1 such as a neurodegenerative diseases (e.g. Alzheimer disease).

Claims (6)

1. A method of treating Alzheimer's disease comprising administering a compound represented by formula (I)

or a pharmaceutically acceptable salt thereof to a patient in need of such treatment.

2. A method of treating non-insulin dependent diabetes comprising administering a compound represented by formula (I)

or a pharmaceutically acceptable salt thereof to a patient in need of such treatment.

3. A method of treating a cognitive and memory deficit characteristic of Alzheimer's disease comprising administering a compound represented by formula (I)

or a pharmaceutically acceptable salt thereof to a patient in need of such treatment.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 19, 2016
From: SANOFI
To: MITSUBISHI TANABE PHARMA CORPORATION
Reel/Frame 040672/0579 →